These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35261100)

  • 21. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
    Saramago P; Yang H; Llewellyn A; Palmer S; Simmonds M; Griffin S
    BJOG; 2018 Oct; 125(11):1414-1422. PubMed ID: 29415334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cell-free foetal DNA fraction in female-foetus bearing pregnancies using X-chromosomal insertion/deletion polymorphisms examined by digital droplet PCR.
    Zednikova I; Pazourkova E; Lassakova S; Vesela B; Korabecna M
    Sci Rep; 2020 Nov; 10(1):20036. PubMed ID: 33208834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Fetal Rhesus D and Gender with Cell-Free DNA and Exosomes from Maternal Blood.
    Yaşa B; Şahin O; Öcüt E; Seven M; Sözer S
    Reprod Sci; 2021 Feb; 28(2):562-569. PubMed ID: 32968935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
    Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
    Hyland CA; O'Brien H; Flower RL; Gardener GJ
    Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia.
    Niguse B; Ermias M; Berhanu S; Abayneh L; Chakiso B; Rather RA
    PLoS One; 2022; 17(3):e0265583. PubMed ID: 35298554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive prenatal testing of beta-thalassemia for common Pakistani mutations: a comparative study using cell-free fetal DNA from maternal plasma and chorionic villus sampling.
    Afzal M; Naeem MA; Ahmed S; Amin N; Rahim A; Munawar M; Ishaq M; Rathore A; Maria K
    Hematology; 2022 Dec; 27(1):353-359. PubMed ID: 35287566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive fetal RhCE genotyping from maternal blood.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
    BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR.
    Eryilmaz M; Müller D; Rink G; Klüter H; Bugert P
    Transfus Med Hemother; 2020 Jul; 47(4):292-301. PubMed ID: 32884502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal typing of Rh- and Kell- blood group system antigens].
    Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry.
    Ekman GC; Billingsly R; Hessner MJ
    Am J Hematol; 2002 Jan; 69(1):34-40. PubMed ID: 11835329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
    Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RHD genotyping from cell-free fetal DNA circulating in pregnant women peripheral blood and sensitivity assessment of innovated diagnostic approaches for introduction into the clinical practice].
    Böhmová J; Vodička R; Lubušký M; Studničková M; Holusková I; Vrtěl R; Kratochvílová R; Frydrychová M; Krejčiříková E; Filipová H
    Ceska Gynekol; 2013 Jan; 78(1):32-40. PubMed ID: 23607381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal RHD genotyping in Croatia: preliminary results.
    Bingulac-Popović J; Babić I; Đogić V; Kundid R; Simović Medica J; Mišković B; Jukić I
    Transfus Clin Biol; 2021 Feb; 28(1):38-43. PubMed ID: 33227453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.